Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > 100% !?!? Oh my !!!
View:
Post by mercedesman on May 19, 2023 8:33am

100% !?!? Oh my !!!

Did Paradigm just go from 75% to 100% Probability of Success ( I.e. assumption of FDA approval) in their latest analysis ?

A done deal?

finito?

fait accompli? 
 
 
Our $ 1.60 rNPV (was $ 1.70) assumes a 100% probability of success in the trial given…and results to date that are exceeding expectations.  Therefore, the $ .26 current share price suggests that the market is only giving the trial a 16% probability of success.  Published industry averages have the probability for a Phase 3 trial at ~63% , or $ 1.00/sh.  This increases to 77% for trials that use a biomarker for patient selection, or $ 1.23/sh.   Therefore, we believe that maket is excessively discounting the potential for success in this Phase 3b trial.


Just wait until this gets distributed to the thousands of Paradigm clients eager to participate in the next late Phase 3 Trial Biotech ! Not to mention thousands of potential US investors as well ! 
 

MM

Comment by MMABStrader on May 19, 2023 11:06am
Mercedesman, can you give us some background info on Paridigm and your understanding of their relationship with Spectral and their potential impact on Spectral's share price. Where are they based? Who is the client base who they influence?
Comment by Stocktree on May 19, 2023 11:08am
Complete BS. Unsubstianted pumping. We are years or yeeeeeeeeeeeeeeears away from the conclusion of this trial. No investment company can assume a trial, which has randomized a little over a third of its patient target will be successful. It it does, it is fraudulent. Spectral themselves would not dare to emit such nonesense. You are just attempting to Gorf out a few quick bucks out of your ...more  
Comment by Accountprince on May 19, 2023 11:29am
Tree boy-did you read the Paradigm report? Or are you opposed to the idea of success? Guess you only want failure. Or else you'd accept the reality of what Paradigm has said. And many many people much smarter than you who are close to the reality. But keep your "sky is falling...sky is falling" garbage to yourself. In the name of decency.
Comment by mercedesman on May 19, 2023 4:23pm
Don't shoot the messenger tree-boy ( aka glass half empty, FUD- slinger )  BTW I find many of the assumptions made by Paradigm, in arriving at their target price,  to be quite conservative.  Maybe I will do a post to explain. MM 
Comment by hmmmmmmmm on May 19, 2023 8:21pm
Paradigm has pumped the same nonsense too many times.  That's why you saw a whole $2k traded on their sparkling analysis... Many remember when they pegged it at some 4 bucks by the End of Year.. Or the very similar pumps as today before the last two or 3 raises- they got well paid and the ones they got to buy in are taking write offs... Not to mention Seto worked there.. of and did ...more  
Comment by mercedesman on May 20, 2023 9:16am
re: 2 k traded Ironically they point out ( quite correctly I might add),  that the market is greatly underappreciating Spectral's probability of success, and yet they themselves are supposed to be one of the main vehicles to getting the word out to the market.  At least they should be, if they are being used to help raise future funds.   Maybe the CRO isn't the only ...more  
Comment by oilandgasman on May 20, 2023 1:13pm
Scotty McShill ready to unload some stock.
Comment by JohnnyCashMoney on May 20, 2023 1:21pm
Scotty Mcshill? Is a liar?
Comment by Accountprince on May 20, 2023 4:12pm
MM is no liar and isn't unloading any stock. He will sell along with other real shareholders when it reaches true value.  Let me explain - there are nefarious types that bash relentlessly to scare anyone away and thereby assist in holding the price down. The BOD and management have done nothing to help the share price with little to no promotion. In fact they benefit greatly from the low ...more  
Comment by Revten on May 21, 2023 6:48am
Hey MM & Accountprince, I could not Agree With You More! There is No Question as to the Successful Outcome!  Just taking longer than EXPECTED.....but the Tigress resulted keep coming out as ABOVE EXPECTATIONS! Exceeding EXPECTATIONS!  The Shareholders that continue to Hold and Buy ....the way I bought lots in the 20's in the last month....will be handsomely Paid ...more  
Comment by SimonSaid on May 21, 2023 2:15pm
Although your postion is very compelling, consideration must be given to the ability to raise enough money to get to the FDA approval.  Also, one can take the position that they will be able to continue to raise money, but at what cost?  Look no further than the Dialco divestiture...burn rate is aproximately $1M per month... I hope you (and others) are correct.
Comment by mercedesman on May 21, 2023 10:06pm
Of course !  Which is why I and others have been pounding the table on more US exposure  starting with OTC-QX and more. When the demand supply equation is broke, you must fix it.  One way means more dilution.  The other likely means way more dilution than is necessary. However, for a Phase 3b confirmatory trial that is exceeding all expectations, and where the need is great ...more  
Comment by oilandgasman on May 22, 2023 10:47am
"Just taking longer than EXPECTED" just a decade longer, no big deal when your investing money.
Comment by mercedesman on May 24, 2023 7:56am
Thx Rev !  youve got mail ! 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities